MINERALYS THERAPEUTICS, INC. (MLYS) Free cash flow 2023–2025
MINERALYS THERAPEUTICS, INC. (MLYS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$142.4MFY2025 · since FY2023: -$81.2M → -$142.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$142.4M | +14.4% |
| FY2024 | -$166.4M | -105.0% |
| FY2023 | -$81.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice